Sartorius AG
Press Release

Sartorius Opens Cell Culture Technology Center in the Scientific Hub of Ulm, Germany

Ulm, Germany, November 18, 2021

The life science group Sartorius officially opened its Cell Culture Technology Center at Science Park III, a major hub for cutting–edge research and scientific discovery near many of Germany’s top universities. Around 120 employees work at this Sartorius facility featuring special laboratories and covering 6,000 square meters, some 65,000 square feet, to develop cell lines and optimize cell culture media, which manufacturers of biologics need to produce advanced medicines and vaccines. Sartorius has invested around 30 million euros on the whole in its Ulm-based Cell Culture Technology Center. The Mayor of Ulm, Gunter Czisch, and the President of the University of Ulm, Prof. Michael Weber, joined the opening ceremony that was held virtually due to the pandemic.

“Our Cell Culture Technology Center enables us to support manufacturers of biopharmaceuticals even more efficiently so that innovative medicines reach patients faster while helping us to drive growth in a key market of tomorrow. For this reason, we will be looking to recruit new employees in the future as well,“ said Hugo de Wit, Head of Cell Culture Technologies at Sartorius and Managing Director of the company’s Ulm site. Currently, Sartorius is offering more than a dozen job positions in Ulm and around 1,300 worldwide.

As a leading international partner of life science research and the biopharmaceutical industry, Sartorius in Ulm develops cell lines and protein production processes, licenses technologies for manufacturing proteins, and offers cell culture media. Proteins produced by living cells are used in the discovery, development, and production of biopharmaceutical medicines and vaccines.

Follow Sartorius on Twitter @Sartorius_Group and on LinkedIn.

Further Information

Ulm: A Cutting-Edge Cell Culture Technology Center

A guided video tour of the site and additional images are available on the Sartorius Blog.

Explore More